[Calcium and bone metabolism across women's life stages. Bone quality and treatment of osteoporosis by SERM]
- PMID: 28439061
[Calcium and bone metabolism across women's life stages. Bone quality and treatment of osteoporosis by SERM]
Abstract
Estrogen deficiency induces bone resorption and bone collagen crosslink abnormalities such as reductions in enzymatic cross-links and accumulation of Advanced glycation end products(AGEs). In this review, we described that the mechanism of poor bone quality in estrogen deficiency and how selective estrogen receptor modulators such as raloxifene and bazedoxifene improve bone structural and material properties.
Similar articles
-
[Effect of raloxifene as a SERM on bone metabolism].Nihon Rinsho. 2006 Apr;64 Suppl 4:411-8. Nihon Rinsho. 2006. PMID: 16689343 Review. Japanese. No abstract available.
-
[SERM and quality of bone].Clin Calcium. 2004 Oct;14(10):96-9. Clin Calcium. 2004. PMID: 15577138 Review. Japanese.
-
New management options for osteoporosis with emphasis on SERMs.Climacteric. 2015;18 Suppl 2:56-61. doi: 10.3109/13697137.2015.1104010. Epub 2015 Oct 27. Climacteric. 2015. PMID: 26503459 Review.
-
[Role of estrogen and selective estrogen receptor modulators in anti-aging].Clin Calcium. 2008 Jul;18(7):986-94. Clin Calcium. 2008. PMID: 18591752 Review. Japanese.
-
[Updates on Lifestyle-Related Diseases and Bone Metabolism. Efficacy of selective estrogen receptor modulators (SERMs) in lifestyle-related osteoporosis].Clin Calcium. 2014 Nov;24(11):1679-87. Clin Calcium. 2014. PMID: 25355152 Japanese.
MeSH terms
Substances
LinkOut - more resources
Medical